Mesna

FDA’s June 2024 list of off-patent, off-exclusivity drugs sees rise in cancer, HIV treatments

This week PharmaCompass brings to you key highlights of the US Food and Drug Administration’s

FDA haunted by problems at Chinese plant; Sun Pharma gets entangled in price gouging furor

Phispers brings you the latest in global pharma news, such as how the drug price hike uproar in the